HR 6757 United States House · 117th Congress

Insulin Savings for Patients Act

Summary

Insulin Savings for Patients Act This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2022

Committee Review

Floor Vote

President

Introduced Feb 18, 2022 Last action Feb 21, 2022

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 21, 2022

Committee

Referred to the Subcommittee on Health.

lower

Feb 18, 2022

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Feb 18, 2022

Introduced

Introduced in House

lower

1 primary · 3 co-sponsors